Journal of Health Sciences & Surveillance System

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

The Epidemiology and Trend of incidence of Hepatitis B and C Infections in Southern Iran (2014-2020)

Document Type : Original Articles

Authors

1 Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Neonatal and Children’s Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran

3 Cohort Research Center, Yasuj University of Medical Sciences, Yasuj, Iran

4 Division of GI/Liver, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA. USA

5 Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran

6 Health Center of Hamedan, Hamedan University of Medical Sciences, Hamedan, Iran

7 Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

8 Department of Health Education and Health Promotion, School of Health, Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran

9 Abadan University of Medical Sciences, Abadan, Iran

Abstract

Background: Viral hepatitis is one of the world’s top five infectious diseases that cause premature death. Each year, at least one million people die from these infections worldwide. This study investigated the epidemiological features and trend of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in Abadan City, southern Iran.
Methods: This cross-sectional study was performed on recorded data of HBV and HCV infections from the notifiable disease surveillance system of Abadan University of Medical Sciences from 2014 to 2020. The incidence per 100,000 population for HBV and HCV infections has been calculated by study years and age groups. The chi-square test was applied to compare various types of infections.
Results: The average age of the participants was 40.47±13.20, ranging from 1-88 years. This study estimated the prevalence of HBsAg-positive cases from 2014 to 2020 as 1.53, 6.92, 7.07, 7.07, 8.15, 3.23, and 3.38 per 100,000, respectively. Also, the incidence of HCV-infected cases during these years were 3.23, 6.46, 11.84, 6.46, 8.92, and 2.15 per 100,000 populations, respectively. The average age of patients varied widely based on the type of hepatitis (P=0.001) so that the mean age in HBV-infected patients was 41.06±12.41 years, 41.76±12.99 years in HCV-infected and 22.93±18.02 years in HBV/HCV-infected patients.
Conclusion: The findings of this study suggest a lower prevalence of hepatitis B and C compared to other regional studies conducted in Iran. In recent years, the incidence of HBV and HCV has declined, indicating the successful implementation of the vaccination plan and observance of health tips in Abadan.

Highlights

Habibollah Azarbakhsh (Google Scholar)
Aliasghar Valipour (Google Scholar)

Keywords

References
  1. Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA. Liver transplantation and hepatitis C. Transplant International: official journal of the European Society for Organ Transplantation. 2002;15(2-3):61-72.
  2. Nateghi Rostami M, Tasbihi M, Ghorbanian P, Najafi Z, Mousavi Miandashti Z. Epidemiologic Status of Viral Hepatitis Infections in Patients Referred to Health Care Centers of Qom Province during 2009-2013. Community Health Journal. 2017;10(1):19-28.
  3. Castelhano N, Araujo NM, Arenas M. Heterogeneous recombination among Hepatitis B virus genotypes. Infection, Genetics and Evolution. 2017;54:486-90. PMID: 28827173.
  4. Erhabor O, Mohammad S, Bello L, Onuigwe F, Abdulrahman Y, Zama I, et al. Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto Nigeria. Human antibodies. 2020(Preprint):1-11. doi: 10.3233/HAB-200412.
  5. Qian L, Wang W, Zhou Y, Ma J. Effects of reduced glutathione therapy on chronic hepatitis B. Cent Eur J Immunol. 2017;42(1):97-100. doi: 10.5114/ceji.2016.65894.
  6. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis. 2004;11(2):97-107. doi: 10.1046/j.1365-2893.2003.00487.x.
  7. Mohammadi M, Mirzaei M, Mahmoudi Kohani HA, Zahednezhad H, Vaisi Raiegan AA, Jalali A, et al. Prevalence of Hepatitis C in Iranian Prisoners (2001-2016): A Systematic Review AND Meta-Analysis. 2018;19 (60)
  8. Nateghi Rostami M, Tasbihi M, Ghorbanian P, Najafi Z, Mousavi Miandashti Zjchj. Epidemiologic Status of Viral Hepatitis Infections in Patients Referred to Health Care Centers of Qom Province During 2009-2013. 2016;10(1):19-28.
  9. Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses. Scientific reports. 2018;8(1):150. doi: 10.1038/s41598-017-18296-9. 
  10. Brown RS, Jr., Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl. 2003;9(11):S10-3. doi: 10.1053/jlts.2003.50244.
  11. Mirminachi B, Mohammadi Z, Merat S, Neishabouri A, Sharifi AH, Alavian SH, et al. Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis. 2017;17(2): e42291. doi: 10.5812/hepatmon.42291.
  12. Zidan A, Scheuerlein H, Schüle S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepatitis monthly. 2012;12(10 HCC). doi: 10.5812/hepatmon.6894.
  13. Kim WR. Epidemiology of hepatitis B in the United States. Hepatology2009. p. S28-34. doi: 10.1002/hep.22975.
  14. Hahne SJ, De Melker HE, Kretzschmar M, Mollema L, Van Der Klis FR, Van Der Sande MA, et al. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiol Infect. 2012;140(8):1469-80. doi: 10.1017/S095026881100224X.
  15. Paoli J, Wortmann AC, Klein MG, Pereira V, Cirolini AM, Godoy BA, et al. HBV epidemiology and genetic diversity in an area of high prevalence of hepatitis B in southern Brazil. Braz J Infect Dis. 2018;22(4):294-304. doi: 10.1016/j.bjid.2018.06.006.
  16. Salimi S, Alijahan R, Nakhostin B, Hazrati S. Prevalence of HbsAg+ Cases and its Associated Factors in Pregnant Women Referred to Health Centers of Ardabil District in 2009. Journal of Health. 2014;5(3):248-58.
  17. Falla AM, Hofstraat SHI, Duffell E, Hahne SJM, Tavoschi L, Veldhuijzen IK. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC Infect Dis. 2018;18(1):79. doi: 10.1186/s12879-018-2988-x.
  18. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55. doi: 10.1016/S0140-6736(15)61412-X.
  19. Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015;21(38):10790-810. doi: 10.3748/wjg.v21.i38.10790.
  20. Salari N, Darvishi N, Hemmati M, Shohaimi S, Ghyasi Y, Hossaini F, et al. Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis. Arch Virol. 2022;167(4):1025-39. doi: 10.1007/s00705-022-05382-1.
  21. Fabrizi F, Donato FM, Messa P. Hepatitis C and Its Metabolic Complications in Kidney Disease. Ann Hepatol. 2017;16(6):851-61. doi: 10.5604/01.3001.0010.5275. 
  22. Mirzaei M, Afzali M, Lotfi MH, Alavinia SM, Fallahzadeh H, Ayatollahi J. Hepatitis B infection in North Khorasan province during march 2010 to February 2012. Journal of North Khorasan University of Medical Sciences. 2014;6(2):425-31.
  23. Ghadir MR, Belbasi M, Heidari A, Sarkeshikian SS, Kabiri A, Ghanooni AH, et al. Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iran. Hepat Mon. 2012;12(3):205-8. doi: 10.5812/hepatmon.847. 
  24. McMahon BJ, Schoenberg S, Bulkow L, Wainwright RB, Fitzgerald MA, Parkinson AJ, et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol. 1993;138(7):544-9. doi: 10.1093/oxfordjournals.aje.a116888.
  25. Kim WR. Epidemiology of hepatitis B in the United States. Hepatology. 2009;49(5 Suppl):S28-34. doi: 10.1002/hep.22975.
  26. Fattahi MR, Safarpour A, Sepehrimanesh M, Hosseini Asl SM, Mohamaddoust F. The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. Hepat Mon. 2015;15(2):e24734. doi: 10.5812/hepatmon.24734. 
  27. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008;14(18):2867-71. doi: 10.3748/wjg.14.2867.
  28. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010;14 Suppl 3:e113-6. doi: 10.1016/j.ijid.2009.11.032. 
  29. Poustchi H, Esmaili S, Mohamadkhani A, Nikmahzar A, Pourshams A, Sepanlou SG, et al. The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study. PLoS One. 2011;6(8):e23830. doi: 10.1371/journal.pone.0023830.
  30. Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian FS, Ajdarkosh H, et al. Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011). Hepat Mon. 2013;13(12):e13313. doi: 10.5812/hepatmon.
  31. Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, Njei B, et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol. 2014;60(4):691-8. doi: 10.1016/j.jhep.2013.11.014.
  32. Ghorbani NR, Djalalinia S, Modirian M, Abdar ZE, Mansourian M, Gorabi AM, et al. Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis. J Res Med Sci. 2017;22:123. doi: 10.4103/jrms.JRMS_223_17.
  33. Hariri S, Sharafkhah M, Alavi M, Roshandel G, Fazel A, Amiriani T, et al. A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting. Harm Reduct J. 2020;17(1):56. doi: 10.1186/s12954-020-00400-4.
  34. Yazhan S, Sohrabi E, Jamili P, Saffari SE, Mojaddadi MS. Frequency of HBV, HCV and HIV infections among Sabzevar blood donors based on demographic characteristics during 2009-2013. The Scientific Journal of Iranian Blood Transfusion Organization. 2016;13(3):197-206. URL: http://bloodjournal.ir/article-1-998-en.html
  35. Jalilian S, Mohamadinejad A, Teimoori A, Javadi S, Mohamadinejad T. Determination of Relative Frequency of HBsAg Positive among Patients Referred to Imam Khomeini Hospital in 2012-14. Jundishapur Scientific Medical Journal. 2017;16(4):425-31.doi: 10.22118/JSMJ.2017.51023.
  36. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol. 2006;12(30):4884-7. doi: 10.3748/wjg.v12.i30.4884.
  37. Mirzaei M, Afzali M, Lotfi M, Alavinia S, Fallahzadeh H, Ayatollahi J. Hepatitis B infection in North Khorasan province during march 2010 to February 2012. North Khorasan University of Medical Sciences. 2014;6(2):425-31. URL: http://journal.nkums.ac.ir/article-1-356-en.html.
  38. Kasraian L, Torab Jahromi SA. Prevalence of major transfusion transmitted viral infections (HCV, HBV, HIV) in Shiraz blood donors from 2000 to 2005. Scientific Journal of Iran Blood Transfus Organ. 2007;3(5):373-8. URL: http://bloodjournal.ir/article-1-133-en.html.
  39. Kasraian L, Torab Jahromi SAJSJoIBTO. Prevalence of major transfusion transmitted viral infections (HCV, HBV, HIV) in Shiraz blood donors from 2000 to 2005. 2007;3(5):373-8. URL: http://bloodjournal.ir/article-1-133-en.html.
  40. Javadzadeh Shahshahani H, Vaziri M, Mansouri F. Seven Years Trends in Prevalence of Transfusion-Transmissible Viral Infections in Yazd blood Transfusion Organization. Iran J Ped Hematol Oncol. 2013;3(3):119-24. PMID: 24575283.
  41. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004;25(1):26-33. PMID: 14758374.
  42. Abdolahi N, Keshtkar A, Semnani S, Roshandel G, Beshrat S, Joshaghani H, et al. HBV Seroprevalence among Golestan adults. Iranian Journal of Epidemiology. 2006;2(3):35-40.
  43. Poorolajal J, Mirzaei M, Bathaei SJ, Majzoobi MM. Hepatitis B and C infections in hamadan province during 2004-2009. 2011. PMID: 22911948.
  44. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology. 2000;31(3):756-62. doi: 10.1002/hep.510310329.
  45. Rezaie M, khaleghian Al. Prevalence of hepatitis B, hepatitis C and HIV in blood donors in Semnan province (Iran) from 2011 to 2015. Koomesh journal. 1394;17(2):501-8. URL: http://koomeshjournal.semums.ac.ir/article-1-2893-en.html.
  46. Gheibipour H, Etemad K, Khodakarim S, Sharhani A, Ebrahimi KS. Prevalence and effect factors of HBV among injection drug users in Kermanshah, Iran in 2016. Iranian Journal of Epidemiology. 2019;15(1). URL: http://irje.tums.ac.ir/article-1-6280-en.html.
  47. Bani Aghil S, Abbasi S, Arab M, Seyedein M. The Prevalence of HCV, HBV, HIV in Blood Donors of Golestan Province,(2006-2008). Medical Laboratory Journal. 2009;3(2):0-. URL: http://mlj.goums.ac.ir/article-1-25-en.html.
  48. Taheri Azbarmi Z, Nouri S, Joukar F, Jafarshad R, Haajikarimian K, Alinejad S, et al. Transfusion transmitted diseases in Rasht blood donors. The Scientific Journal of Iranian Blood Transfusion Organization. 2008;4(5):337-43. URL: http://bloodjournal.ir/article-1-203-en.html.
  49. Yazhan S, Sohrabi E, Jamili P, Saffari S, Mojaddadi MS. Frequency of HBV, HCV and HIV infections among Sabzevar blood donors based on demographic characteristics during 2009-2013. Scientific Journal of Iran Blood Transfus Organ. 2016;13(3):197-206. URL: http://bloodjournal.ir/article-1-998-en.html.
Journal of Health Sciences & Surveillance System
Volume 11, Issue 4
October 2023
Pages 760-768
Files
Share
How to cite
Statistics